Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France

BACKGROUND: Five diseases are currently screened on dried blood spots in France through the national newborn screening programme. Tandem mass spectrometry (MS/MS) is a technology that is increasingly used to screen newborns for an increasing number of hereditary metabolic diseases. Medium chain acyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamers, Françoise F, Rumeau-Pichon, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464722/
https://www.ncbi.nlm.nih.gov/pubmed/22681855
http://dx.doi.org/10.1186/1471-2431-12-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464722/
https://www.ncbi.nlm.nih.gov/pubmed/22681855
http://dx.doi.org/10.1186/1471-2431-12-60

Ejemplares similares